The human CD4 + CD25
+ T cell population contains a lineage of regulatory T (T reg ) cells capable of modulating conventional immune responses [1, 2] . Characterized by their constitutive expression of CD25, T reg cells suppress proliferation of and cytokine release in responder cells via a mechanism involving cell-cell contact and inhibition of IL-2 transcription [3] . In animal models as well as in human disease, deficiency of T reg cells has been linked to autoimmunity, suggesting that T reg cells play a key role in the maintenance of peripheral immunological self-tolerance [4] . Because of their broad, non-antigen specific suppression of immune responses, CD4 + CD25 + T reg cells may, in addition, contribute to the outcomes of infection, tumor immunity, and transplantation [5] . Human CD4 + CD25 + cells comprise a mixed population consisting of conventional activated T cells expressing CD25 as well as T reg cells, and the suppressive activity of T reg cells has been demonstrated in the fraction with the highest CD25 expression [6] . Several strategies that have been described to distinguish T reg cells from conventional activated T cells include examination of CD4 + T cells with the highest (top 2%-3%) CD25 expression [7] and the use of additional surface markers, such as CD45RO and CD27, in conjunction with CD25 [8, 9] . More recently, Foxp3, a transcription factor of the forkhead/winged-helix family, has been demonstrated to specifically identify T reg cells. Several lines of evidence indicate that Foxp3 is a critical mediator of the development and function of T reg cells. Foxp3 expression is highly enriched in the CD4 + CD25 + T cell subpopulation exhibiting suppression [8] . In gene-transfer experiments, Foxp3 expression has been shown to be sufficient to convert naive T cells to the regulatory phenotype and to confer suppressor function [8, 10] . Mutations in the Foxp3 gene have been shown to lead to multiorgan autoimmune disease in mice and humans, suggesting a loss of immunological self-tolerance in the setting of a defect in Foxp3 expression [11] . Of the molecules associated with T reg cells, Foxp3 appears to be a unique marker for them [12] .
A number of studies have implicated impaired Foxp3 expression in the pathogenesis of human inflammatory diseases. Viglietta et al. [13] demonstrated an impaired suppressive capacity of CD4 + CD25 high T cells in patients with multiple sclerosis (MS), compared with those in healthy donors. Subsequently, Hong et al. [14] and Huan et al. [15] reported impaired Foxp3 transcription in patients with MS, compared with that in healthy donors. In another study, patients with juvenile idiopathic arthritis (JIA) had a decreased frequency of peripheralblood CD4 + CD25
high cells, compared with that in healthy volunteers [16] . When individuals with a self-limiting form of JIA were compared with those with a less-favorable prognosis, the patients with the self-limiting JIA had a relatively higher frequency of CD4 + CD25 high cells and a relatively higher expression of Foxp3. Similarly, examination of synovial fluid in patients with JIA showed a higher ratio of T reg cells to activated effector T cells in patients with limited disease, compared with that in patients with more-extensive disease [9] .
Infection with human T lymphotropic virus type 1 (HTLV-1) is associated with reduced Foxp3 expression in those individuals who develop the inflammatory neurologic disease termed "HTLV-1-associated myelopathy/tropical spastic paraparesis" (HAM/TSP) [17] . In addition to the chronic inflammatory myelopathy of HAM/TSP, a number of multiorgan inflammatory disorders-including myositis, alveolitis, sialadenitis, arthritis, and uveitis-are seen in these patients [18] [19] [20] [21] , suggesting a generalized disorder of immune regulation. Remarkably, examination of the peripheral blood of patients with HAM/TSP shows persistent expansion of activated T cells and hypergammaglobulinemia. Furthermore, peripheral-blood leukocytes (PBLs) from patients with HAM/TSP exhibit spontaneous lymphoproliferation during ex vivo culture in the absence of exogenous stimulants [22] . These features of HAM/TSP suggest an underlying systemic inflammatory process, such that a defect in T reg cells could potentially account for a number of its manifestations.
Here, we developed a flow-cytometric assay to directly study Foxp3 protein expression among human PBLs as a marker of T reg cells. We characterized the phenotype of Foxp3-expressing cells among PBLs from healthy donors with respect to a number of associated surface markers. We then analyzed endogenous Foxp3 expression during HTLV-1 infection by comparing Foxp3 expression in healthy donors, in asymptomatic HTLV-1 carriers, and in patients with HAM/TSP. The results suggest that a reduction in Foxp3 expression is associated with disease manifestation during HTLV-1 infection.
SUBJECTS, MATERIALS, AND METHODS
PBL samples. PBLs were obtained from patients with HAM/ TSP and asymptomatic HTLV-1 carriers at the National Institute of Neurological Diseases and Stroke (Bethesda, Maryland), under a protocol approved by its Institutional Review Board. Written, informed consent was obtained from each subject. Demographic and clinical characteristics of the study subjects are summarized in table 1. Unless otherwise specified, all PBL samples were cryopreserved.
Antibodies. Among the antibodies screened, 2 rabbit antihuman Foxp3 polyclonal antibodies (ab10901 and ab4728; Abcam) that recognized different epitopes on Foxp3 and 1 mouse anti-human Foxp3 monoclonal antibody (ab22510; Abcam) showed comparable intensities of specific Foxp3 staining and were used for analysis of Foxp3 expression in human PBLs. The mouse monoclonal antibody was used for all analyses comparing Foxp3 expression in the patients with HAM/TSP, the asymptomatic HTLV-1 carriers, and the healthy donors. Cy5-labeled goat anti-rabbit immunoglobulin F(ab ) 2 (Jackson ImmunoResearch) and Cy5-labeled goat anti-mouse immunoglobulin F(ab ) 2 (Caltag Laboratories) were used as secondary antibodies. AlexaFluor 546-labeled goat anti-rabbit antibody (Invitrogen) was used as the secondary antibody for immunofluorescence microscopy. Phycoerythrin (PE)-or fluorescein isothiocyanate (FITC)-labeled anti-CD25, PE-or FITC-labeled anti-CD4, PE-labeled cytotoxic T lymphocyte-associated antigen (CTLA)-4, FITC-labeled anti-CD45RO, and FITC-labeled anti-CD27 were all obtained from BD Pharmingen. using an ABI PRISM 7700 Sequence Detector (Applied Biosystems), as described elsewhere [17] . The primers for Foxp3 were 5 -GGCCCTTCTCCAGGACAGA-3 and 5 -GCTGATCA-TGGCTGGGTTGT-3 , and the probe was 5 -FAM-ACTTCAT-GCATCAGCTCTCCACTGTGGATTAMRA-3 . The gene for hypoxanthine ribosyl transferase (HPRT; primers and probe set from Applied Biosystems) was used as a housekeeping gene, to calculate normalized values of Foxp3 mRNA expression. The normalized values in each sample were calculated as the relative quantity of Foxp3 mRNA expression divided by the relative quantity of HPRT mRNA expression. The values were calculated using the following formula: normalized Foxp3 mRNA (Ct value of HPRT Ϫ Ct value of Foxp3) , where "Ct" is the cycle expression p 2 threshold.
HTLV-1 proviral tax DNA load determination. HTLV-1 proviral tax DNA load was measured using an ABI PRISM 7700 Sequence Detector (Applied Biosystems), as described elsewhere [23] . DNA was extracted from cells using a 6 1 ϫ 10 Puregene DNA Isolation Kit (Gentra); 100 ng of the sample DNA solution per well was analyzed using this system. All samples were analyzed in triplicate. The HTLV-1 tax proviral DNA load was calculated using the following formula: copy number of HTLV-1 tax per 100 (copy number of cells p [ tax copy number of b-. )/( actin/2)] ϫ 100 Flow cytometry. HEK 293T cells were washed and then fixed by sequential formaldehyde/methanol fixation, as described elsewhere [24] with the following modifications. After careful resuspension, cells were fixed with 100 mL of reagent A (Fix and Perm Kit; Caltag Laboratories) for 3 min at room temperature. Two milliliters of precooled (4ЊC) 70% methanol was then added to the tubes for 5 min at 4ЊC. Cells were centrifuged and then washed twice in PBS containing 5% fetal calf serum (FCS) and 0.1% NaN 3 . Cells were permeabilized with 100 mL of Reagent B (Fix and Perm Kit) and stained with anti-human Foxp3 antibody (0.2 mg of ab10901, 0.5 mg of ab4728, or 0.5 mg of ab22510) or the appropriate isotype control immunoglobulin for 30 min. Cells were washed twice, permeabilized with reagent B, and stained with Cy5-conjugated goat anti-rabbit or goat anti-mouse IgG F(ab ) 2 for 30 min. Cells were washed twice and then analyzed using a FACSCalibur system (BD Biosciences).
Cryopreserved PBLs were thawed and washed in PBS containing 5% FCS and 0.1% NaN 3 . Surface markers were stained for 20 min at 4ЊC before fixation when using the rabbit polyclonal anti-Foxp3 antibody and after fixation and Foxp3 staining when using the mouse monoclonal anti-Foxp3 antibody. Intracellular staining for human Foxp3 was performed as described above. Flow-cytometric data analysis was performed using FlowJo (version 6.3; Tree Star).
Statistical analysis.
Statistical analysis was performed using generalized linear model analysis of variance, with the 3 subject groups as fixed-effect factors. P values are from pairwise comparisons. Commercially available anti-human Foxp3 antibodies were screened for flow-cytometric detection of human Foxp3 using the Foxp3/EGFP cell line. To enhance the detection of Foxp3 by flow cytometry, additional fixation with 70% methanol was used. The sequential formaldehyde/methanol fixation improved detection of Foxp3 by flow cytometry, compared with that with formaldehyde fixation alone ( figure 1D and 1E) .
RESULTS

Enhancement
The specificity of Foxp3 detection using this method was tested by analyzing HEK 293T cells transiently transfected with the Foxp3/EGFP vector, negative control vectors, and untransfected HEK 293T cells ( figure 1G-1K ). Foxp3 was detected in the HEK 293T cells transfected with the Foxp3/EGFP vector (figure 1G) but not in the HEK 293T cells transfected with a + CD25 high T cell population, whereas Foxp3 expression was significantly lower in the CD4 + CD25 low T cell population. A survey of phenotypic markers of lymphocytes confirmed that the Foxp3-expressing cells were positive for CD3 and CD4 but showed negligible CD8 staining (figure 3). Markers of B cells, monocytes, and NK cells-CD19, CD14, and CD56-were also absent on Foxp3-expressing cells (data not shown). As was expected, the Foxp3-expressing cells showed high surface expression of CD25, exhibiting a positive correlation be- tween the expression of these 2 molecules. Similarly, intracellular CTLA-4 expression was high in Foxp3-expressing cells, although high levels of CTLA-4 staining were also seen in cells that did not express Foxp3. A survey of T cell accessory molecules demonstrated that the Foxp3-expressing cells were positive for CD62L, CD45RO, CD27, and CD28. CD122 expression was relatively low on Foxp3-expressing cells within the total lymphocyte gate but was relatively high when gating was on total CD4 + T cells. Foxp3-expressing cells showed high levels of Fas (CD95) expression but showed low levels of CD95L expression (data not shown). Foxp3-expressing cells were CD69 negative. This phenotypic profile of Foxp3-expresing cells, as demonstrated by flow cytometry, is in agreement with the profile of human T reg cells that has been reported in the literature [6, 8] .
Lower expression of Foxp3 in patients with HAM/TSP. To define the population of T reg cells in the patients with HAM/ TSP, the CD4 + CD25 + T cell population was analyzed for intracellular expression of Foxp3 in comparison with that in the healthy donors and the asymptomatic HTLV-1 carriers. Representative histograms for the healthy donors and the patients with HAM/TSP with respect to CD4, CD25, and Foxp3 expression by PBLs are shown in figure 2A and 2C, ). The relative Foxp3 expression in 58.6% ‫ע‬ 6.9% P p .04 CD4 + CD25 + cells from the HTLV-1-infected subjects (the patients with HAM/TSP and the asymptomatic HTLV-1 carriers) was also analyzed with respect to HTLV-1 tax proviral DNA load. As has been previously reported [23] , the patients with HAM/TSP had higher HTLV-1 tax proviral DNA loads than did the asymptomatic HTLV-1 carriers (table 1) . Linear regression showed an inverse correlation between Foxp3 expression and proviral DNA load (figure 5) in the HTLV-1-infected subjects.
In addition, the CD4 + CD25 + T cell population was analyzed for surface expression of CD45RO and CD27, because these markers have been reported to distinguish T reg cells (CD45RO or CD27 positive) from conventional activated T cells (CD45RO or CD27 negative) in the CD4 + CD25 + T cell population among PBLs and at sites of inflammation [8, 9] . The majority of CD4 + CD25 + cells among PBLs from the healthy donors were positive for CD27 and CD45RO (88.8% and 91.9%, respectively). Analysis of CD45RO expression in the CD4 + CD25 + T cell population showed no difference between the healthy donors and the patients with HAM/TSP (data not shown). However, a relatively low expression of CD27 in the CD4 + CD25 + T cell population of the patients with HAM/TSP suggested a reduction in T reg cells. Samples from the patients with HAM/TSP showed a lower proportion of CD27 + CD4 + CD25 + cells (79%; ) and significantly P p .079 lower CD27 expression as measured by fluorescence intensity (figure 6A), compared with that in the healthy donors ( ). The CD27 Ϫ CD4 + CD25 + cells showed low Foxp3 P p .024 expression, which is in agreement with the findings of a previous study [9] . In addition, the CD27 low CD4 + CD25 + cells also showed low Foxp3 expression, compared with the CD27 high CD4
+ CD25 + T cell population ( figure 6D ). Thus, among PBLs from patients with HAM/TSP, only a fraction of the CD27 + CD4 + CD25 + cells are likely to be T reg cells, whereas both CD27 Ϫ CD4 + CD25 + and CD27 low CD4 + CD25 + cells likely represent conventional activated T cells.
DISCUSSION
Recently, a number of studies have examined the role played by T reg cells in human immune-mediated diseases [9, 13, 17, 25] . The heterogeneity of the CD4 + CD25
+ T cell population, which is composed of conventional activated T cells as well as T reg cells, presents a challenge for the isolation and study of T reg cells. Although constitutive expression of CD25 is a characteristic of T reg cells, CD25 is also expressed on activated effector T cells [4] . The Foxp3 protein has been shown to be a T reg cellspecific marker whose expression is a critical mediator of the development and function of these cells [12] . A number of studies have suggested that an acquired defect in Foxp3 expression may contribute to human diseases [13, 17, 25] .
There is a paucity of reports describing Foxp3 expression, particularly those using flow-cytometric techniques. This may be the result of technical difficulties in the use of commercially available anti-Foxp3 reagents and the detection of low-frequency T cell populations. We have developed a method for detecting Foxp3 by flow-cytometric analysis of human PBLs. Sequential formaldehyde/methanol fixation before intracellular staining enhances the specific detection of Foxp3 in human PBLs. Similar methods have been used successfully in the past to detect other transcription factors and nuclear antigens [24] . This method produced comparable results with the rabbit polyclonal and mouse monoclonal anti-human Foxp3 antibodies that were used in the present study. The use of a transfected HEK 293T cell line that stably overexpressed Foxp3 and EGFP provided a robust and reliable positive control for the rapid screening of antibodies and fixation protocols.
Foxp3 expression in PBLs from healthy donors was highest in the CD4 + CD25 + T cell population, which is in agreement with the findings of a study examining Foxp3 mRNA expression by real-time RT-PCR [8] . The positive correlation between the relative expression of CD25 and Foxp3 and between the relative expression of CTLA-4 and Foxp3 shown by flow-cytometric analysis of PBLs is also in agreement with the results of genetransfer experiments linking Foxp3 expression with the upregulation of CD25 and CTLA-4 [8] . Flow-cytometric analysis of Foxp3-expressing cells also allowed for the characterization of other cell-surface molecules associated with T reg cells [6, 8, 9] . Foxp3-expressing cells also expressed CD62L, CD45RO, CD28, and CD27. High expression of CD95 on T reg cells has been previously reported and was associated with susceptibility to apoptosis in this population [26] . In the present study, although analysis of the total CD4 + CD25
+ T cell population revealed a range of CD95 expression (data not shown), the Foxp3-expressing cells exhibited the highest degree of CD95 expression. Expression of CD95L was negligible in these ex vivo PBL analyses. Studies are under way to determine whether Foxp3-expressing cells modulate the expression of any of these markers after activation of T reg cells.
We recently demonstrated reduced Foxp3 expression in CD4 + CD25 + T cells in patients with HAM/TSP, compared with that in healthy donors [17] . In addition, we showed in that study that the HTLV-1-encoded transactivating factor Tax may be involved in down-regulating Foxp3 transcription. Here, we extended this observation by comparing Foxp3 expression in patients with HAM/TSP with that in asymptomatic HTLV-1 carriers. Foxp3 expression was reduced in PBLs from patients with HAM/TSP, compared with that in PBLs from asymptomatic HTLV-1 carriers and healthy donors. There was no significant difference in the mean level of Foxp3 expression in CD4 + CD25 + T cells between the asymptomatic HTLV-1 carriers and the healthy donors. Consistent with the findings of a previous study [23] , the patients with HAM/TSP demonstrated a 6-fold increase in HTLV-1 tax proviral DNA load, compared with that in the asymptomatic HTLV-1 carriers. This was associated with a reduction in the frequency of Foxp3 + CD4 + CD25 + cells as the level of HTLV-1 tax proviral DNA increased. Therefore, the reduced Foxp3 expression in the patients with HAM/TSP relative to that in the asymptomatic HTLV-1 carriers suggests a role for HTLV-1 Tax in down-regulating Foxp3 transcription and function [17] .
The specific determinants of disease risk in HTLV-1 infection are not completely understood. A small fraction (∼3%) of individuals infected with HTLV-1 develop HAM/TSP [27] . Although asymptomatic carriers typically maintain relatively low HTLV-1 tax proviral DNA loads (table 1), the development of HAM/TSP in individuals infected with HTLV-1 is associated with high proviral loads [28] . In addition, a protective effect has been attributed to certain HLA alleles and cytokine polymorphisms that are associated with a lower incidence of disease [29] . The present finding of reduced Foxp3 expression in PBLs from patients with HAM/TSP suggests that a reduction in the frequency of T reg cells may contribute to the development of HAM/TSP. One could postulate that, in the setting of high HTLV-1 proviral DNA load, increased transcription of tax [23] may lead to the down-regulation of Foxp3 and an impaired capacity of T reg cells, ultimately leading to unchecked inflammatory responses in the host. The asymptomatic HTLV-1 carriers with relatively lower Foxp3 expression are of particular interest in this context, because it would be informative to prospectively follow them to determine whether lower , compared with that in the mean ‫ע‬ SE 34.0% ‫ע‬ 1.4% healthy donors ( , ) and in the asympmean ‫ע‬ SE 10.1% ‫ע‬ 1.6% tomatic HTLV-1 carriers ( , ), which mean ‫ע‬ SE 10.2% ‫ע‬ 1.2% is consistent with the findings of previous studies. A reduction in the frequency of T reg cells in such a setting raises the question of whether a simple "dilution" of T reg cells has occurred via an expansion of the population of conventional activated CD4 + CD25 + T cells. We previously demonstrated that the transfection of Tax into T reg cells from healthy donors resulted in reduction of Foxp3 transcription and impaired function of T reg cells [17] . Therefore, there is evidence to indicate that a viral mechanism exists in HAM/TSP that actively down-regulates Foxp3 expression. In addition, given that the suppression of conventional immune responses by T reg cells likely occurs through a cell contact-dependent mechanism, even a dilutional reduction in the frequency of T reg cells may be functionally significant.
